Waldenström macroglobulinemia terminating in acute leukemia: a report of three cases

American Journal of Hematology
D E HorsmanL F Skinnider

Abstract

Acute leukemia was observed to develop in three patients with Waldenstöm macroglobulinemia. Each patient had been treated with cytotoxic drug therapy. Pancytopenia preceded the onset of the terminal leukemia in two of the three cases. The acute leukemias were all of acute myelogenous type. All of the patients died soon after the development of the terminal leukemia. A number of recent reports have documented acute terminal leukemia in patients with macroglobulinemias and multiple myeloma, as well as other malignant and nonmalignant diseases. The role of the cytotoxic drugs, especially chlorambucil, cyclophosphamide, and melphalan, in leukemogenesis has been raised by these recent reports.

References

Jan 1, 1979·Medicine·D A Casciato, J L Scott
Apr 1, 1977·Blood·M R MacKenzie, T K Lee
Mar 1, 1975·The American Journal of Medicine·F Rosner, H Grünwald
Sep 1, 1965·Immunochemistry·G ManciniJ F Heremans
Feb 19, 1981·The New England Journal of Medicine·P D BerkL R Wasserman
Jul 1, 1959·Archives of Biochemistry and Biophysics·F W PUTNAMR A PHELPS

❮ Previous
Next ❯

Citations

Jan 1, 1988·Springer Seminars in Immunopathology·D Geltner
Jul 1, 1995·Critical Reviews in Oncology/hematology·E Pascali
Oct 29, 2002·Leukemia & Lymphoma·Morie A Gertz
Jan 11, 1991·Cancer Investigation·D C CaseD L Redfield
Jul 13, 2001·American Journal of Clinical Pathology·C M RosalesL J Medeiros
Aug 4, 2007·British Journal of Haematology·Rafael Fonseca, Suzanne Hayman
Apr 10, 2007·Leukemia Research·K J PhekooUNKNOWN South Thames Haematology Specialist Committee
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Kun YangTaixiang Wu
Dec 22, 1998·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·K OoharaA Kobayashi
Jun 2, 2005·American Journal of Hematology·Morie A Gertz
Dec 5, 2020·Leukemia·Lisa Marie KaiserChristian Buske
Jan 1, 1988·Critical Reviews in Oncology/hematology·R A Kyle, P A Greipp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.